| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479716A Propionic acid derivatives with PPAR-alpha activating properties |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479630A Method of inducing cancer cell death and tumor regression |
| 03/03/2004 | CN1479629A Combinations and compositions which interfere with VEGF/VEFG and anglopoietin/Tie receptor function and their use (II) |
| 03/03/2004 | CN1479624A Process for preparing aqueous extracts of plants and extracts so obtained |
| 03/03/2004 | CN1479623A Antimonocytic activity of extracts of piper betel leaves |
| 03/03/2004 | CN1479619A Use of pyrazolo [4,3-d] pyrimidines |
| 03/03/2004 | CN1479609A Oral delivery of peptide |
| 03/03/2004 | CN1478902A Ganoderma mycellium antitumour water soluble neteropolysaccharide and its preparation method and use |
| 03/03/2004 | CN1478792A Oyster low molecular active peptide and its preparation method and application in the preparation of anticancer medicine |
| 03/03/2004 | CN1478782A Germanium caffeiate and its preparation technology |
| 03/03/2004 | CN1478552A Carrier used for carrying radiation substance and its use method |
| 03/03/2004 | CN1478544A Use of polypeptide protein kind active substance in Arca inflate Roeve and its extraction method |
| 03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
| 03/03/2004 | CN1478541A Design of high effect blood vessel production inhibitor and its application |
| 03/03/2004 | CN1478538A Chinese medicinal composition for treating prostate cancer, its preparation method and its application in the preparation of medicine for treating prostate cancer |
| 03/03/2004 | CN1478537A Chinese medicinal composition for anti-cancer and analgesia, its preparation method and its application in the preparation of product and medicine for treating cancer and analgesia |
| 03/03/2004 | CN1478495A Chinese Medicinal composition for anticancer and its preparation method |
| 03/03/2004 | CN1478481A Etoposide enteric slow (controlled) release solid dispersing preparation and its preparation method |
| 03/03/2004 | CN1478479A New use of verbascum glycoside |
| 03/03/2004 | CN1478469A Capsule possessing antiinflammation, releaving pain and anticancer function and its preparation method |
| 03/03/2004 | CN1140627C Recombinant virus of human vascular endothelial growth inhibitor |
| 03/03/2004 | CN1140520C Tetrahydrofurans |
| 03/03/2004 | CN1140516C Quinoline and quinoxaline compounds which inhibits platelet-derived growth factor on/or p56lck tyrosine kinases |
| 03/03/2004 | CN1140509C Novel vitamin D. analogues |
| 03/03/2004 | CN1140508C Substed 4-biphenyl-4-hydroxybutyric acid derivs, and matrix metalloprotease inhibitors |
| 03/03/2004 | CN1140297C Stabilized pharmaceutical compositions and stabilizing solvent |
| 03/03/2004 | CN1140281C Yiyuansan powder as oral medicine for treating liver cancer and its preparation method |
| 03/03/2004 | CN1140272C Antitumor agents |
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/03/2004 | CN1140262C Prepn. of nano hdyroxycamptothecine-dextran grain |
| 03/03/2004 | CN1140182C Coca components, edible products having enhanced polyphenol content, methods of making same and medical us |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699902 Anticancer agents |
| 03/02/2004 | US6699901 Water solubility, nontoxic, side effect reduction; anticarcinogenic agents |
| 03/02/2004 | US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels |
| 03/02/2004 | US6699888 Antiinflammatory |
| 03/02/2004 | US6699887 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection |
| 03/02/2004 | US6699883 Antibiotics, bactericides, antitumor |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 03/02/2004 | US6699876 Camptothecin analogue compounds |
| 03/02/2004 | US6699875 Cascade esters of camptothecins and methods of treating cancer using these compounds |
| 03/02/2004 | US6699872 N-substituted urea inhibitors of farnesyl-protein transferase |
| 03/02/2004 | US6699871 Such as 7-((3r)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders |
| 03/02/2004 | US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699861 Anti-quinazoline compounds |
| 03/02/2004 | US6699854 2-substituted 4-heteroaryl- pyrimidines, inhibitors of cyclin-dependent kinases (cdks) |
| 03/02/2004 | US6699844 Methods for treating cellular proliferative disorders |
| 03/02/2004 | US6699835 Formulation of boronic acid compounds |
| 03/02/2004 | US6699833 Pharmaceutical formulations for sustained drug delivery |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699672 Heparanase specific molecular probes and their use research and medical applications |
| 03/02/2004 | US6699483 Cancer treatments |
| 03/02/2004 | CA2198247C Ionene polymers containing biologically-active anions |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/26/2004 | WO2004017336A1 Process for producing ferromagnetic fine-particle exothermic element |
| 02/26/2004 | WO2004016769A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | WO2004016764A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 02/26/2004 | WO2004016622A1 Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
| 02/26/2004 | WO2004016614A2 Pyrrolopyrazines as kinase inhibitors |
| 02/26/2004 | WO2004016613A2 Purine derivatives and their use as antiproliferative agents |
| 02/26/2004 | WO2004016612A2 New purine derivatives |
| 02/26/2004 | WO2004016597A2 Protein kinase inhibitors and uses thereof |
| 02/26/2004 | WO2004016587A1 Nitrogen-containing compounds |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | WO2004016317A1 Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/26/2004 | WO2004016285A1 Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer |
| 02/26/2004 | WO2004016272A1 Use of reboxetine for the treatment of hot flashes |
| 02/26/2004 | WO2004016257A1 A composition comprising phytospingosine derivatives for apoptosis induction |
| 02/26/2004 | WO2004005328A3 Peptidomimetic compound useful as inhibitor of integrins |
| 02/26/2004 | WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles |
| 02/26/2004 | WO2004000237A3 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 02/26/2004 | WO2003106505A9 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 02/26/2004 | WO2003103584A3 Ether substituted imidazopyridines |
| 02/26/2004 | WO2003103575A3 Compounds, compositions, and methods |
| 02/26/2004 | WO2003101444A8 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer |
| 02/26/2004 | WO2003101374A3 Use of new etonogestrel esters |
| 02/26/2004 | WO2003099211A3 Mitotic kinesin inhibitors |
| 02/26/2004 | WO2003098991A3 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 02/26/2004 | WO2003098223A3 A method for killing cells by inhibiting histone activity in the cell |
| 02/26/2004 | WO2003097855A3 Small molecule inhibitors of her2 expression |
| 02/26/2004 | WO2003090684A3 Polymer compositions containing a macrocyclic triene compound |
| 02/26/2004 | WO2003088970A3 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/26/2004 | WO2003087841A3 An ephrin-b receptor protein involved in carcinoma |
| 02/26/2004 | WO2003087333A3 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 02/26/2004 | WO2003074008A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 02/26/2004 | WO2003073998A3 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 02/26/2004 | WO2003070234A9 Alkylating agent combinations in the treatment of cancer |
| 02/26/2004 | WO2003064443A3 New corticosteroids |
| 02/26/2004 | WO2003060085A3 Mammalian neural stem cells, compositions and uses thereof |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 02/26/2004 | WO2003057822A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |